VigyanBangMD

Cardiology • Joplin, MO

Echocardiography, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiac Critical Care

Interventional and Structural Cardiologist, Medical Director of Structural Cardiology, Freeman Health System. Assistant Prof of Medicine at Kansas City University

Join to view full profile

Dr. Bang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bang's full profile

Already have an account?

Office
1102 W 32nd St Ste 300
Joplin, MO 64804
Phone+1 417-347-5000

Education & Training

University of Maryland Medical CenterStructural Cardiology, 2021 - 2022
University of MarylandFellowship, Interventional Cardiology, 2020 - 2021
Lahey ClinicFellowship, Cardiovascular Disease, 2017 - 2020
Lahey ClinicResidency, Internal Medicine, 2014 - 2017
Seth G.S. Medical CollegeClass of 2012

Certifications & Licensure

MO State Medical License 2021 - 2025
MA State Medical License 2014 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Outstanding PGY1 of the year Lahey Hospital and Medical Center, 2015

Publications & Presentations

PubMed

55 citations
Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week.
Vigyan Bang, Sarju Ganatra, Sachin P. Shah, Sourbha S. Dani, Tomas G. Neilan
Journal of the American College of Cardiology. 2021-03-02
17 citations
Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study.
Nathan H Raines, Sarju Ganatra, Pitchaphon Nissaisorakarn, Amar Pandit, Alex Morales
Kidney360. 2021-01-28
3 citations
In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
Vigyan Bang, Mph Michael S. Levy Md
Catheterization and Cardiovascular Interventions. 2016-01-01

Lectures

True or False: A Percutaneous Closure of Aortic Pseudoaneurysm
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

COVID-19 in Cardio-Oncology PopulationJanuary 2021

Press Mentions

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-AnalysisJanuary 21st, 2016